Though it may seem counterintuitive, antidiabetic medications that improve blood glucose may worsen this condition
When used alongside menopausal hormone therapy, they can provide a synergistic approach that addresses both the hormonal decline and the resulting metabolic challenges
So, most compounded versions of the popular weight loss drug tirzepatide will no longer be available
GLP-1 receptor agonists like semaglutide influence brain reward pathways that regulate eating and substance use, which may explain reductions in alcohol consumption and binge drinking observed in research and patient reports
Similar content being viewed by others Log in or create a free account to read this content Gain free access to this article, as well as selected content from this journal and more on nature.com or References Fleming TP, Watkins AJ, Velazquez MA, Mathers JC, Prentice AM, Stephenson J, et al